ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

cannabis sativa flowering TOP

Also written as “Cannabis oil”, “MGCND00EP1” and “Medical Grade Cannabis oil”.

Its studies are mostly in Drug Resistant Epilepsy · Attention Deficit Disorder with Hyperactivity · Autistic Disorder · Hidradenitis Suppurativa, led by 5 companies.

Drug pageCannabis sativa flowering TOP: every studyMany companies study it; this page follows only the 6 they lead. All 15 studies, academic ones too, with its approvals and label.
Furthest: phase 2, since Apr 24, 20196 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
TO Pharmaceuticalsits history only20 open or runningphase 2since Apr 24, 2019Apr 24, 2019none ahead
Brlev Agricultural Cropsits history only10 open or runningphase 2since Dec 30, 2021Dec 30, 2021none ahead
GreenCare Pharmaits history only11 open or runningphase 1since Jan 17, 2025Jan 17, 2025none ahead
MGC Pharmaceuticals d.o.oits history only10 open or runningphase 2since May 17, 2020May 17, 2020none ahead
New Age Ventures10 open or runningphase 1since Jul 29, 2020Jul 29, 2020none ahead

Also a collaborator on its studies: Bio-Sciences Pharma and KGK Science.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of New Age Ventures only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 29, 2020First study: phase 1 study in Marijuana AbuseFirst studyNCT04601207 · 32 enrolled · Canada

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study New Age Ventures leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT04601207Marijuana Abuse · Canada1CompletedNov 30, 202032

How it is read

Names in the registry

  • “Cannabis oil”, 3 entries
  • “MGCND00EP1”, 1 entry
  • “Medical Grade Cannabis oil”, 1 entry
  • “Cannabis Preparation”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.